NEW YORK (TheStreet) -- CHANGE IN RATINGS

Abbott Laboratories

(ABT) - Get Report

rated new Buy at Stifel. $40 price target. Company can generate solid and consistent earnings growth.

Atmel

(ATML)

upgraded at Craig-Hallum from Hold to Buy, Craig-Hallum said. $9 price target. Market conditions are improving and the company will likely score some big content wins.

Progressive Waste Solutions

(BIN)

upgraded to hold at TheStreet Ratings.

Coca-Cola Hellenic Bottling Company

(CCH) - Get Report

downgraded to hold at TheStreet Ratings.

Comerica

(CMA) - Get Report

downgraded at Citigroup to Sell from Neutral. $31 price target. Valuation stretched.

Centurylink

(CTL) - Get Report

downgraded at DA Davidson from Neutral to Underperform, DA Davidson said. $30 price target. Company cut its dividend and may see future dilution.

Davita

(DVA) - Get Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Valuation call, as the stock is up 67% over the past 14 months. $120 price target.

EnCana

(ECA) - Get Report

downgraded at UBS to Neutral from Buy, UBS said. $21 price target. No longer expect a shift in strategy.

General Motors

(GM) - Get Report

downgraded at Craig-Hallum from Buy to Hold, Craig-Hallum said. Company lacks near-term catalysts. $30 price target.

Generac

(GNRC) - Get Report

downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Expect organic sales growth to slow down. $29 price target.

Generac upgraded at Stifel. GNRC was upgraded from Hold to Buy, Stifel Nicolaus said. $42 price target. Stock is attractive, following a post-earnings selloff.

Huntington Bancshares

(HBAN) - Get Report

downgraded at Citigroup to Neutral from Buy, Citigroup said. $7.25 price target. Valuation call.

Netgear

(NTGR) - Get Report

upgraded at Sterne Agee from Neutral to Buy, Sterne Agee said. $41 price target. Company has multiple potential growth drivers for the second half of the year.

Northwestern

(NWE) - Get Report

downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Valuation call.

Oceaneering

(OII) - Get Report

downgraded at BMO to Market Perform, BMO Capital said. Valuation call, based on a $62 price target.

Pioneer Natural

(PXD) - Get Report

downgraded at Canaccord to Sell, Canaccord Genuity said.Valuation call, based on a $113 price target.

QEP Resources

(QEP) - Get Report

upgraded at Sterne Agee from to Neutral, Sterne Agee said. Outlook appears more balanced ahead of earnings.

Transocean

(RIG) - Get Report

downgraded at Deutsche from Hold to Sell, Deutsche Bank said. $49 price target. Fleet downtime is increasing.

SunTrust Banks

(STI) - Get Report

downgraded at Jefferies to Hold from Buy, Jefferies said. $30 price target. Revenue trajectory concerns.

Triumph

(TGI) - Get Report

rated new Outperform at Wells. Company should see volume growth from new programs.

Urban Outfitters

(URBN) - Get Report

downgraded at BMO from Outperform to Market Perform, BMO Capital said. $45 price target. Anthropologie turnaround is lagging.

STOCK COMMENTS / EPS CHANGES

Alexion Pharmaceuticals

(ALXN) - Get Report

numbers lowered at Jefferies. Shares of ALXN now seen reaching $88, Jefferies said. Estimates also lowered on delay in Soliris launch. Hold rating.

Alpha Natural

(ANR)

numbers increased at Credit Suisse. ANR estimates were raised through 2014, Credit Suisse said. Company is cutting cash costs. Neutral rating and new $10 price target.

Discovery

(DISCA) - Get Report

estimates, target reduced at Lazard. DISCA estimates were raised through 2014, Lazard Capital Markets said. Company is facing a higher tax rate. Buy rating and new $90 price target.

EOG Resources

(EOG) - Get Report

target raised at Jefferies to EOG now seen reaching $155, Jefferies said. Higher Eagle Ford potential. Buy rating.

Generac

(GNRC) - Get Report

numbers raised at Oppenheimer. Shares of GNRC now seen reaching $44, Oppenheimer said. Estimates also raised on positive outweighing the negatives. Outperform rating.

Incyte Corp

(INCY) - Get Report

numbers lowered at Jefferies. Shares of INCY now seen reaching $36, Jefferies said. Estimates also lowered on guidance take down. Buy rating.

Pharmacyclics

(PCYC)

estimates, target raised at Credit Suisse. Shares of PCYC now seen reaching $90, accoridng to Credit Suisse. Estimates also increased, as Ibrutinib should drive growth. Outperform rating.

Pepsi

(PEP) - Get Report

estimates, target boosted at Morgan Stanley. Shares of PEP now seen reaching $81, according to Morgan Stanley. Estimates also raised, given higher organic sales growth. Overweight rating.

Qlik Technologies

(QLIK)

numbers raised at Jefferies. Shares of QLIK now seen reaching $28, Jefferies said. Estimates also lowered on higher license expectations. Hold rating.

TAL International Group

(TAL) - Get Report

target raised at Jefferies to $46, Jefferies said. Residual value drives earnings beat. Hold rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>Will Amazon Drop 30% Like Apple?

>>Can Dish Blow Up the Spectrum Market?

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.